From CDC Information Database
This database includes general CDC public health information on specific diseases and health related topics. When available, the database displays genomic information from various CDC web pages. Users are also encouraged to conduct searches of CDC website for additional information.
- CDC Medscape Expert Commentary: Genetics and BRCA in Primary Care
by Katherine Kolor, Medscape, October 13, 2014 - Knowing BRCA Changed My Life
By Debbie Wasserman Schultz, CDC Blog Post 2014 - CDC Know:BRCA Tool
Some women carry certain genetic changes in their BRCA genes that increase their risks for getting breast, ovarian, and other kinds of cancers at a young age
From CDC-Authored Genomics Publication Database
This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.
- Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Bellcross Cecelia A et al. Cancer Epidemiol. Biomarkers Prev. 2013 Apr 22(4) 728-35 - Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Trivers Katrina F et al. Cancer 2011 Dec 1. 117(23) 5334-43
From Implementation Database
This database focuses on state and national activities that integrate genomics into public health programs and clinical practice
- MICHIGAN BRFSS SURVEILLANCE BRIEF
[Disease: Breast Cancer|Ovarian Cancer; Type: Data; State: Michigan] - BRCA video: English version
[Disease: Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States] - BRCA Patient - Spanish version 2016
[Disease: Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States] - http://www.mdedge.com/jcso/article/110048/gynecologic-cancer/hereditary-breast-and-ovarian-cancer-risk-assessment-minority
[Disease: Breast Cancer|Ovarian Cancer; Type: Data|Program; State: Georgia] - The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
[Disease: Breast Cancer|Ovarian Cancer; Type: Multipe Types; State: Georgia|Michigan|Oregon]
From Guideline Database
This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.
- SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
Published 2015 (Sociedad Espanola de Oncologia Medica (SEOM)) - Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families.
Published 2015 (Expert panel) - BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
Published 2015 (Clinical Working Group of ENIGMA) - BRCA1 and BRCA2 genetic testing - pitfalls and recommendations for managing variants of uncertain clinical significance.
Published 2015 (Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group) - Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
Published 2012 (US Preventive Services Task Force)
From Tier Table Database
CDC Office of Public Health Genomics (OPHG) conducts horizon scanning (a systematic research method to find and follow novel technologies appearing in the literature) to identify and track the progress of genomic tests as they move from research into clinical and public health practice. As an aid in organizing horizon scanning results, OPHG ranks genomic tests, and family health history applications, by levels of evidence. See detail.
| Disease/Disorder | Test to be Assessed | Intended Use | Tier Classified | Detail |
|---|---|---|---|---|
| Hereditary breast/ovarian cancer | Routine BRCA genetic counseling, routine BRCA testing | Population screening | Tier 3  | |
| Hereditary breast and ovarian cancer | Family history of known breast/ovarian cancer with deleterious BRCA mutation | Risk prediction; referral to counseling for BRCA genetic testing | Tier 1 | |
| BRCA-related cancer; hereditary breast and ovarian cancer | Family history | Risk prediction for referral for BRCA genetic counseling | Tier 1 |
From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology
- Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review.
Journal of Korean medical science 2017 Feb 32 (2): 377-381.
Song Won Hoon, Kim Sung Han, Joung Jae Young, Park Weon Seo, Seo Ho Kyung, Chung Jinsoo, Lee Kang Hy - Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Journal of the National Cancer Institute 2017 Jan 109 (1): .
Kotsopoulos Joanne, Huzarski Tomasz, Gronwald Jacek, Singer Christian F, Moller Pal, Lynch Henry T, Armel Susan, Karlan Beth, Foulkes William D, Neuhausen Susan L, Senter Leigha, Tung Nadine, Weitzel Jeffrey N, Eisen Andrea, Metcalfe Kelly, Eng Charis, Pal Tuya, Evans Gareth, Sun Ping, Lubinski Jan, Narod Steven A, - Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.
BMC cancer 2016 Dec 16 (1): 934.
Maistro Simone, Teixeira Natalia, Encinas Giselly, Katayama Maria Lucia Hirata, Niewiadonski Vivian Dionisio Tavares, Cabral Larissa Garcia, Ribeiro Roberto Marques, Gaburo Junior Nelson, de Gouvêa Ana Carolina Ribeiro Chaves, Carraro Dirce Maria, Sabino Ester Cerdeira, Diz Maria Del Pilar Estevez, Chammas Roger, de Bock Geertruida Hendrika, Folgueira Maria Aparecida Azevedo Koi - Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.
JAMA oncology 2016 Dec .
Priedigkeit Nolan, Hartmaier Ryan J, Chen Yijing, Vareslija Damir, Basudan Ahmed, Watters Rebecca J, Thomas Roby, Leone Jose P, Lucas Peter C, Bhargava Rohit, Hamilton Ronald L, Chmielecki Juliann, Puhalla Shannon L, Davidson Nancy E, Oesterreich Steffi, Brufsky Adam M, Young Leonie, Lee Adrian - Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.
Oncotarget 2016 Dec 7 (51): 85529-85541.
Chao Angel, Chang Ting-Chang, Lapke Nina, Jung Shih-Ming, Chi Peter, Chen Chien-Hung, Yang Lan-Yan, Lin Cheng-Tao, Huang Huei-Jean, Chou Hung-Hsueh, Liou Jui-Der, Chen Shu-Jen, Wang Tzu-Hao, Lai Chyong-Hu
From From Genomics & Health Impact Scan Database
This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.
- Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer.
Listøl Wenche et al. Hereditary cancer in clinical practice 2017 152 - Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
Hayden Sommer et al. Journal of genetic counseling 2017 Jan - A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Buys Saundra S et al. Cancer 2017 Jan - Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
Gietel-Habets J J G et al. Human reproduction (Oxford, England) 2017 Jan - Understanding Genetic Breast Cancer Risk: Processing Loci of the BRCA Gist Intelligent Tutoring System.
Wolfe Christopher R et al. Learning and individual differences 2016 Jul 49178-189
.png)
No hay comentarios:
Publicar un comentario